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Abstract: Toll-like receptors (TLRs) are archetypal pattern recognition receptors of immediate importance 
for an efficacious innate immune response. TLRs exhibit marked differential tissue activity and their levels 
within a discrete cell type can be highly dynamic. Of 13 known mammalian paralogues, three TLRs have 
been identified in the dog. Although cardiac TLR expression has been reported in other species, this study 
is the first to present evidence that these innate immune receptors are expressed in the canine heart. Heart 
tissue samples from all four chambers were collected from healthy dogs immediately after euthanasia and 
stored at -80ºC until analysis. Total RNA was extracted with TRI Regent. Specific primers were designed 
for amplification of canine TLR2 and TLR4 based on previously reported sequences for these genes. 
Reverse transcription was performed with M-MLV reverse transcriptase. PCR amplification was 
performed and PCR products analyzed by agarose gel electrophoresis. Bands were excised from the gel 
and the DNA isolated and cloned using the TA Cloning® Kit. The correct sequence for each product was 
verified by nucleotide sequencing. TLR4 expression was detected in the left ventricle and right atrium; 
TLR2 was detectable at low levels in the right atrium only. Identity of the RT-PCR products was 
confirmed by sequencing. Our findings show that at least two TLR paralogues – namely TLR2 and TLR4 – 
are expressed in the canine heart. Additional studies are warranted to determine these immune receptors’ 
potential implication in the development of naturally occurring heart disease in the dog. 
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INTRODUCTION 
 
Progress in the field of acquired immunity has 
historically overshadowed the field of immunology 
entirely[1]. More recent advances have, however, proven 
that innate defense mechanisms play key roles in a 
number of disease processes, and that several different 
so-called ‘danger-signals’ (infectious as well as non-
infectious) may act as the trigger mechanism for an 
immune response[2]. Toll-like receptors (TLRs) are 
highly conserved classical pattern recognition receptors 
of the innate immune system, enabling the host to 
discriminate between pathogen associated molecular 
patterns (PAMPs) and self[1]. Detection of microbial 
components by TLRs also triggers activation of 
adaptive immunity, furthermore making this receptor 
family an important link between the two branches of 
the immune system[3,4]. The mammalian TLR family 
includes thirteen paralogues with differential tissue and 
cellular expression varying between species[1,3]. 
Different microbial patterns, such as lipopolysaccharide 
(LPS) from Gram-negative bacteria, lipotechoic acid 
(LTA) from Gram-positive bacteria and viral dsDNA, 
can act as ligands for different TLRs[1,3,5,6]. Following 
tissue damage, TLRs may also recognize certain host 
proteins, such as beta-defensins and heat shock 
proteins[1]. TLR-mediated signaling occurs through 
either a MyD88-dependent or MyD88-independent 
pathway, and it has been established that TLRs are 
complicit in not only immunological responses but also 
more general cellular homeostasis[1,5]. Toll-Like 
Receptor 4 (TLR4) was the first mammalian TLR 
identified, and it is consequently the best described of 
the family[3,7]. Information on TLRs in small animal 
species is still quite sparse. Recently, the full-length 
cDNA for TLR4 was cloned in dogs and cats[8], and 
TLR2 expression has been identified in canine blood 
phagocytes[9]. Furthermore, the expression of TLR9 has 
been investigated in canine tissues[10], and TLR 
expression has been reported in feline lymphoid 
tissues[11]. Additional studies have been conducted 
pertaining to TLR expression in other domestic 
animals, and TLRs have thus been identified in various 
organs of different species[12-17]. Increasing attention is 
paid to innate immunity and inflammation in heart 
disease and further identification of receptors and 
effector molecules of innate immunity is thus 
warranted. Virtually all cell types of the human and 
murine heart express TLRs[18]. TLR2-4, and TLR6 are 
readily detectable in cardiomyocytes[19,20], while TLR1-
6 are expressed on endotheliocytes, smooth muscle 
cells and macrophages of the vasculature[18]. A recent 
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study suggests that mRNA expression of all ten human 
TLRs can be identified in the adult heart in people[21]. It 
has been suggested that endogenous signals, such as 
oxidative stress and heat shock proteins, can activate 
TLR-mediated signaling pathways in isolated 
ventricular cardiomyocytes[19]. Furthermore, the 
activation of myocardial TLR-mediated signaling 
pathways in response to exogenous ligands can induce 
cardiac dysfunction[22,23]. TLR2 has also been 
implicated in ventricular remodeling after myocardial 
infarction in mice[24]. No studies to date have reported 
on TLR expression in the canine heart. Since TLRs are 
essential signaling molecules governing an innate 
immune response, and because mediators of 
inflammation and innate immunity with increasing 
certainty are proven to play key roles in different types 
of cardiovascular diseases, we hypothesized that the 
normal canine heart expresses TLRs as a natural part of 
its intrinsic defense system. Here we show that TLR2 
and TLR4 are expressed in whole heart homogenate 
from normal dogs. Further studies pertaining to TLR 
function and regulation in the canine heart are needed to 
establish the significance of these receptors in the heart 
of dogs in health and disease. 
 
MATERIALS & METHODS 
 
Tissue preparation: Heart tissue samples were 
collected from healthy dogs immediately after 
euthanasia and snap-frozen in liquid nitrogen. Separate 
samples were obtained from both ventricles and atria. 
All animals were treated in strict accordance with 
university IACUC guidelines. Samples were 
temporarily stored at -80ºC until further analysis. 
 
RNA extraction: Total RNA was extracted with TRI 
Regent (Sigma-Aldrich, St. Louis, MO) after grinding 
the frozen tissues in liquid nitrogen. Briefly, total RNA 
was treated with RQ1 RNase-free DNAse I (Promega, 
Madison, WI) to remove possible genomic DNA 
contamination. 
 
Identification and cloning of TLR2 and TLR4 in the 
canine heart: To initiate our investigation of canine 
cardiac TLRs, specific primers were designed for 
amplification of canine TLR2 and TLR4 based on the 
previously reported sequences for these genes 
(GenBank No. NM_001005264 and NM_001002950). 
TLR2 forward and reverse primers sequences were 5′- 
ATGATTCCTACTGGGTGGAGAAC and 5′-
CGCAGCTTACAGAATCGCTG, respectively. TLR4 
forward and reverse primers sequences were 5′- 
CCTGGAAGGACTGTGCAATT and 5′-
TGCTTCAGTCTGGTTGTCCC, respectively.  
Using the designed primers and total RNA (from each 
heart tissue section) as template, reverse transcription 
was performed with M-MLV (Moloney Murine 
Leukemia Virus) reverse transcriptase (Invitrogen, 
Carlsbad, CA) following the instructions of the 
manufacturer, in a 20-µl reaction containing 500 ng of 
total RNA and two-base anchored oligo(dT) primers 
(5′-(dT)14VN, where N is any base and V is G, A or C). 
The template cDNA (1 µl) was amplified by PCR in a 
volume of 20 µl containing 1 µM of each primer and 
2.5 units of Taq DNA polymerase (Promega). PCR 
amplification was performed by 35 cycles consisting of 
template denaturation (94°C, 15 sec), primer annealing 
(55°C, 30 sec) and polymerization (72°C, 1 min). PCR 
products were analyzed by agarose gel electrophoresis. 
To confirm the specificity of the amplification products, 
bands were excised from the gel and the cDNA isolated 
and cloned using the TA Cloning® Kit (Invitrogen, 
Carlsbad, CA) and sequenced. Full cDNA sequences 
were compared with previously reported canine TLR2 
and TLR4 sequences using the BLAST tool from the 
National Center of Biotechnology Information. 
 
RESULTS AND DISCUSSION 
 
Expression of TLR4 was detected in cardiac tissue 
samples originating from the left ventricle and right 
atrium; TLR2 expression was detectable at low levels in 
the right atrium only. No expression of either TLR2 or 
TLR4 was found either in the left atrium or right 
ventricle. Nucleotide sequences obtained from the RT-
PCR products were compared to previously described 
canine toll-like receptor nucleotide sequences and 
displayed complete homology. Tissue expression of 
TLR2 and TLR4 mRNA is shown in Fig. 1. 
 
Fig. 1:  Tissue expression of TLR2 and TLR4 mRNA. Total 
RNA (500 ng) was subjected to RT-PCR and 10l 
of 35-cycle amplicons were separated on 2% 
agarose gel and stained with ethidium bromide. Top 
gel: TLR2, Bottom gel: TLR4. m: size markers; LA: 
left atrium, RV: right ventricle, LV: left ventricle, 
RA: right atrium. TLR2 and TLR4 amplicons (blue 
arrow) were 310 and 420 bp in size, respectively.  
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Innate immunity and inflammation play central roles in 
a variety of pathologies - including common 
cardiovascular disorders, as shown in humans as well as 
rodent models[25]. It is likely that specific effector 
molecules and signaling pathways governing an innate 
immune response are of key importance to the 
development of certain types of naturally occurring 
heart diseases in dogs and other domestic animals. 
TLRs are an ancient pattern recognition system central 
for signaling in innate immunity[6]. TLR2 expression 
has been reported in canine blood phagocytes[9], and 
TLR4 and TLR9 have been identified in selected dog 
tissues[8,10,26]. To date, no study has reported on TLR 
expression in the dog heart. Knowledge of the 
expression pattern of these receptors in the normal 
canine heart is, however, of immediate importance for 
further mechanistic studies pertaining to innate 
immunity and the heart. The present work provides 
novel evidence that at least two TLRs - TLR2 and 
TLR4 - are expressed in the canine heart. We also 
report that TLR2 expression was detectable in the right 
atrium only, while TLR4 could be identified in the left 
ventricle as well as the right atrium. The global 
expression of TLRs changes secondary to intrinsic 
factors such as age, as well as cellular exposure to 
environmental stressors including pathogenic 
microorganisms[1]. Distinct TLRs may also affect each 
other’s expression levels, and functional dimerization of 
certain TLRs has been reported[5]. A key design feature 
entails the trafficking of certain TLRs (TLR1-2 and 
TLR4-6) to the cell membrane thus allowing interaction 
with extracellular pathogens, while other TLRs (TLR3 
and TLR7-9) are found virtually only at intracellular 
sites  – this division, however, is not absolute[1]. The 
heart possesses a germ-line encoded innate stress 
system, which is activated in response to different types 
of injury[27]. Since TLRs are ancient germ-line encoded 
receptors of an innate immune response, and the right 
atrium the first location reached by blood entering the 
heart from the systemic circulation, it may be theorized 
that the expression of TLRs in this chamber is 
constitutive and possibly more diverse compared to 
other cardiac sites to allow early detection of noxae. 
Similarly, constitutive expression of TLR4 in the left 
ventricle would be advantageous as an intrinsic measure 
of detection situated immediately prior to blood leaving 
the heart and entering the main coronaries and systemic 
circulation. Bacterial LPS is the classical ligand for 
TLR4 activation (although other endogenous substances 
have been suggested as possible TLR4 stimulants also), 
whereas TLR2 recognizes a variety of microbial 
components, including LTA from Gram-positive 
bacteria[3,6,28]. TLR2 has also been implicated as a 
mediator of staphylococcal induced cardiodepression by 
acting as a receptor for proinflammatory cytokines such 
as tumor necrosis factor (TNF) and interleukin-1β (IL-
1β) (both of which are known contributors to cardiac 
decompensation in sepsis)[25]. In isolated coronary 
endothelial cells, TLR4 is required for LPS-signaling 
leading to an inflammatory response[29]. TLR4 is also a 
known contributor to development of chronic rejection 
after heart transplantation[30]. Interestingly, one study 
reports that cardiomyocytes and endotheliocytes have 
an equal amount of TLR4, but that only the latter 
responds to LPS, possibly making the need for 
cardiomyocytes as detectors obsolete[31]. However, TLR 
expression observed in cardiomyocytes may function as 
a back-up system that is activated after longer exposure 
to a pathogen or other noxia, thus serving as receptors 
in a “second line of defense” of an innate immune 
response. Further studies on the expression and function 
of TLRs within the frame work of an intrinsic cardiac 
immune response are needed as this may facilitate 
development of future novel treatment modalities in 
canine heart disease. 
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